Clearstead Advisors, LLC Vaccinex, Inc. Transaction History

Clearstead Advisors, LLC

  • $6.31 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$2.01 - $3.0 $602 - $900
-300 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$2.09 - $5.11 $627 - $1,533
300 New
300 $1,000

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $51.6M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email